Reduced platelet activation and platelet aggregation in patients with alcoholic liver cirrhosis

Area of Science:

• Hematology
• Hepatology
• Clinical Biochemistry

Background:

• Previous studies on platelet function in liver cirrhosis show conflicting results.
• Alcoholic liver cirrhosis is associated with altered hematological parameters.
• Understanding platelet behavior is crucial for managing cirrhotic patients.

Purpose of the Study:

• To investigate platelet activation and aggregation in patients with alcoholic liver cirrhosis.
• To compare platelet function between cirrhotic patients and healthy controls.
• To explore the relationship between platelet function, platelet count, and liver disease severity.

Main Methods:

• Utilized a flow cytometry approach to assess platelet activation and aggregation, independent of platelet count.
• Employed light transmission aggregometry (LTA) for platelet aggregation analysis in patients with adequate platelet counts.
• Stimulated platelets with various agonists including adenosine diphosphate, thrombin receptor-activating peptide, arachidonic acid, collagen, and collagen-related peptide.

Main Results:

• Patients with alcoholic liver cirrhosis exhibited significantly lower median platelet counts compared to healthy individuals.
• Platelet activation levels, particularly after stimulation with collagen-related peptide, were reduced in cirrhotic patients.
• Flow cytometry revealed diminished platelet aggregation in response to collagen-related peptide and adenosine diphosphate in patients.
• LTA indicated reduced collagen-induced platelet aggregation in a subset of patients.

Conclusions:

• Platelet function, encompassing activation and aggregation, is impaired in patients with alcoholic liver cirrhosis.
• The severity of platelet dysfunction is associated with both reduced platelet count and the clinical severity of liver cirrhosis (Child-Pugh class B/C).
• These findings highlight the impact of alcoholic liver cirrhosis on platelet hemostatic capacity.